-
-
-
-
-
-
-
Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments
-
-
-
-
-
-
-
Biohaven Reports First Quarter 2022 Financial Results and Reports Recent Business Developments
-
-
-
-
-
-
-
BIOHAVEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND RECENT BUSINESS DEVELOPMENTS
-
-
-
-
-
-
-
Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States
-
-
-
-
-
-
-
Biohaven To Report Third Quarter 2021 Financial Results And Recent Business Developments On November 9, 2021
-
-
-
-
-
-
-
Biohaven Announces Preliminary 2Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment
-
-
-
-
-
-
-
Biohaven Announces Preliminary 1Q2021 Net Product Revenue For NURTEC ODT
-
973,681 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All